Autolus Therapeutics PLC
NASDAQ:AUTL

Watchlist Manager
Autolus Therapeutics PLC Logo
Autolus Therapeutics PLC
NASDAQ:AUTL
Watchlist
Price: 4.39 USD 7.86% Market Closed
Updated: May 19, 2024
AUTL
/
Income Statement
/
Net Income (Common)

Autolus Therapeutics PLC
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Autolus Therapeutics PLC
Net Income (Common) Peer Comparison

Comparables:
CNTA
EXAI
BCYC
IMCR
GNS

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Autolus Therapeutics PLC
NASDAQ:AUTL
Net Income (Common)
-$208.4m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Net Income (Common)
-$151.1m
CAGR 3-Years
-142%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Net Income (Common)
-£146m
CAGR 3-Years
-72%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Net Income (Common)
-$168.2m
CAGR 3-Years
-44%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Net Income (Common)
-£55.3m
CAGR 3-Years
9%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Net Income (Common)
£33.4m
CAGR 3-Years
-8%
CAGR 5-Years
N/A
CAGR 10-Years
3%

See Also

What is Autolus Therapeutics PLC's Net Income (Common)?
Net Income (Common)
-208.4m USD

Based on the financial report for Dec 31, 2023, Autolus Therapeutics PLC's Net Income (Common) amounts to -208.4m USD.

What is Autolus Therapeutics PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
-14%

Over the last year, the Net Income (Common) growth was -40%. The average annual Net Income (Common) growth rates for Autolus Therapeutics PLC have been -14% over the past three years .

ALPHA SPREAD
Join more than 138,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.